Category: Gene Therapy
Oceania Gene Therapy
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Barth Syndrome Treatment Market, By Therapeutic Approaches (Enzyme Replacement Therapy, Gene Therapy, Supportive Care, Stem Cell Therapy, and Others (Small Molecule Drugs)), By Drug Classes (Cardiolipin Precursors, Antioxidants, Immunomodulators, Antibiotics, Dietary Supplements, and Others), By Route of Administration (Oral, Intravenous, and Others (Intramuscular and Topical)), By End User (Hospitals, Specialty Clinics, Research Institutions, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Route of Administration (Oral, Intravenous, and Others (Intramuscular and Topical)), By End User (Hospitals, Specialty Clinics, Research Institutions, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) The global ... Read More
-
Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research ... Read More
-
Global Cell and Tissue Preservation Market, By Type (Cell (Mammalian Cells, Others (Microorganisms and Plant Cells)), Tissue (Blood, Bone, Soft Tissues, Skin)), By Product (Equipments (Kits & Reagents, Freezers & Refrigerators, Storage Systems, Others), Software, Bio-preservation Media, Home-brew Media , Pre-formulated Media), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, Research & Development), By End User (Biobanks & Cell banks, Hospitals & Diagnostics Labs, Research Laboratories, Others), By Preservation Technique (Cryopreservation, Ambient Temperature Storage, Temperature-controlled Storage, Drying / Freeze-Drying, Radiation , Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Bio-preservation Media, Home-brew Media , Pre-formulated Media), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, Research & Development), By End User (Biobanks & Cell banks, Hospitals & Diagnostics Labs, Research Laboratories, Others), ... Read More
-
Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Recombinant DNA technology is the joining together of DNA molecules from two different ... Read More
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
Asia Pacific Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The Asia Pacific microcarriers market is expected to grow from US$ 366.14 ... Read More
-
Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Spinal ... Read More
-
Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The gene therapy market size is expected to grow from ... Read More
-
Global Primary Cell Culture Market, By Product Type (Primary Cells, Instruments, Reagents and Supplements, Media, Other Consumables), By Cell Type (Human Primary Cells, Animal Primary Cells,), By Application (Cell & Gene Therapy Development, Vaccine Production, Drug Discovery and Development, Cancer Research, Prenatal Diagnosis, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Drug Discovery and Development, Cancer Research, Prenatal Diagnosis, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle ... Read More
-
Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033
... million in 2023 and is expected to reach $2,233.6 million by 2033, growing at a CAGR of 18.01% during the forecast period 2023-2033. The cell and gene therapy manufacturing quality control (QC) market is projected ... Read More
-
Viral Vector Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global market for viral vector manufacturing has witnessed remarkable growth over the past decade. In 2024, the market recorded revenue of US$ 800 million, and it is projected to reach a valuation of US$ ... Read More
-
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... North America Leads with a Dominant Market Share The global rare disease treatment market is on an upward trajectory, with the genetic diseases segment expected to maintain its dominance in the coming years, according to ... Read More
-
Asia Pacific Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Asia Pacific cell and gene therapy manufacturing services market is expected to grow from US$ 1,007.42 ... Read More
-
Fanconi Anemia Drug Market, By Treatment Type (Hematopoietic Growth Factors, Gene Therapy, Stem Cell Transplantation, and Other Therapies), By Age Group (Pediatric Patients and Adult Patients), By Disease Stage (Early-stage Disease and Advanced-stage Disease), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) The fanconi anemia drugs are pharmaceutical therapies and treatments that have been created or are currently being researched with the goal of ... Read More
-
Australia Regenerative Medicine Market, By Therapy Type (Cell Therapy, Stem Cell Therapy, Tissue Engineering, Gene Therapy); By Application (Wound Care, Musculoskeletal, Oncology, Dental, Duchenne Muscular Dystrophy), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Medicine Market Size Set to Touch USD 1.4 Billion by 2029 Australia regenerative medicine market is flourishing because of the increasing prevalence of chronic diseases and injuries, growing demand for minimally invasive, personalized treatments, and ... Read More
-
Plasmid DNA Manufacturing Market, By Product Type (Viral Vectors, Plasmid DNA and Non-viral Vectors), By Grade (GMP Grade, R&D Grade and Clinical Grade), By Application (DNA Vaccines, Gene Therapy, Immunotherapy, RNA Vaccines and Others), By Manufacturing Type (Outsourcing and In-house Manufacturing), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics and Marketed Therapeutics), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Manufacturing Type (Outsourcing and In-house Manufacturing), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics and Marketed Therapeutics), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity ... Read More
-
Global Regenerative Medicine Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Stem Cells), Material (Synthetic Material, Biomaterial, and Genetically Engineered Material), Application (Dermatology, Musculoskeletal, Wound Healing, Oncology, Cardiovascular, and Ophthalmology), and Region (North America, Europe, Asia Pacific, and Latin America Middle East, and Africa (LAMEA))
... Healing, Oncology, Cardiovascular, and Ophthalmology), and Region (North America, Europe, Asia Pacific, and Latin America Middle East, and Africa (LAMEA)) Market Overview: Regenerative medicine is a process to restore human cells, tissues, and organs. It ... Read More
-
Cell Culture Market, by Product Type (Instruments and Consumables), by Application (Vaccine Production, Gene Therapy, Cancer Research, Tissue Culture, Drug Development, and Others), by End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The technique of growing cells outside the human body itself is a ... Read More
-
Electroporation Instrument Market, by Product Type (Systems and Accessories (Electrodes, Cuvettes, Chambers, Kits, Others)), by Application (Protein Production, Drug Delivery, Biomedical Research, Gene Therapy, Ablation (Oncology, Cardiology, Others), Others), By Mode (In-Vitro/Clinical and In-Vivo), by End user (Biopharmaceutical, Companies, Hospitals, Research & Academic, Institutes, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... End user (Biopharmaceutical, Companies, Hospitals, Research & Academic, Institutes, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Electroporation ... Read More
-
Hemophilia Gene Therapy Market, by Hemophilia Type (Hemophilia A and Hemophilia B), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Hemophilia is a genetic bleeding disorder in which an individual lacks or has low levels of proteins called clotting factors. There are around 13 types of clotting factors that work with blood platelets, which are ... Read More
-
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Recombinant DNA (rDNA) technology is a novel technique that has led to advances in a number of ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
Research Assistance
